Wellington Management Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,746,382
Closed -$64.8M 2028
2019
Q4
$64.8M Sell
7,746,382
-3,136,700
-29% -$28.8M 0.01% 692
2019
Q3
$98.5M Sell
10,883,082
-156,903
-1% -$1.76M 0.02% 551
2019
Q2
$119M Buy
11,039,985
+6,726,532
+156% +$71.5M 0.03% 520
2019
Q1
$41.1M Buy
4,313,453
+2,264,728
+111% +$23.1M 0.01% 808
2018
Q4
$23.5M Buy
2,048,725
+879,507
+75% +$10.9M 0.01% 942
2018
Q3
$19.8M Buy
1,169,218
+1,016,644
+666% +$15.5M ﹤0.01% 1087
2018
Q2
$2.17M Sell
152,574
-23,443
-13% -$389K ﹤0.01% 1706
2018
Q1
$3.34M Buy
176,017
+43,515
+33% +$930K ﹤0.01% 1606
2017
Q4
$2.17M Buy
+132,502
New +$1.97M ﹤0.01% 1718
2016
Q3
Sell
-85,500
Closed -$495K 2231
2016
Q2
$495K Sell
85,500
-45,200
-35% -$288K ﹤0.01% 1917
2016
Q1
$791K Buy
+130,700
New +$785K ﹤0.01% 1860
2015
Q4
Sell
-413,720
Closed -$2.33M 2234
2015
Q3
$2.33M Buy
413,720
+2,140
+0.5% +$17.6K ﹤0.01% 1588
2015
Q2
$4.57M Buy
411,580
+6,540
+2% +$84.3K ﹤0.01% 1430
2015
Q1
$6.35M Buy
405,040
+9,660
+2% +$149K ﹤0.01% 1374
2014
Q4
$6.01M Sell
395,380
-53,100
-12% -$645K ﹤0.01% 1393
2014
Q3
$4.84M Buy
448,480
+43,360
+11% +$566K ﹤0.01% 1448
2014
Q2
$6.19M Buy
+405,120
New +$5.83M ﹤0.01% 1404
2013
Q3
Sell
-67,800
Closed -$530K 2228
2013
Q2
$530K Buy
+67,800
New +$592K ﹤0.01% 1912

Other funds holding SGMO

Wellington Management Group's SGMO Position: Q1 2020 in Review

Wellington Management Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 7,746,382 shares — an estimated $64.8M sold.

Wellington Management Group first reported a position in SGMO in Q2 2013 and held it in 18 quarters. The position peaked at $119M in Q2 2019. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

  • Wellington Management Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
  • Wellington Management Group sold 7,746,382 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $64.8M.
  • Wellington Management Group first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 18 quarters.
  • Wellington Management Group's SANGAMO THERAPEUTICS INC position peaked at $119M in Q2 2019.
  • 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.